- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: DPP-4 inhibitor (sitagliptin)
Total 2690 results
-
Merck Sharp & Dohme LLCCompleted
-
Michael A. NauckCompleted
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
TakedaCompletedDiabetes MellitusUnited States, Mexico
-
Forest LaboratoriesPhenomixTerminated
-
LG ChemNot yet recruitingHealthy Volunteers
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedMyocardial Infarction | Heart Failure | Ischemic Stroke | Type2 Diabetes | Cardiovascular Death | All-Cause MortalityCanada
-
GlaxoSmithKlineNo longer availablePrimary Myelofibrosis | Myelofibrosis
-
Sierra Oncology, Inc.TerminatedPolycythemia Vera | Essential ThrombocythemiaUnited States, France, Germany, Canada, Australia
-
Kanazawa UniversityUnknownType 2 Diabetes Mellitus | Chronic Liver DiseaseJapan
-
Boryung Pharmaceutical Co., LtdCompletedHypertension | DiabetesKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedBioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and MetforminUnited States
-
Hospital de Especialidades, Centro Medico Nacional...National Polytechnic Institute, MexicoCompleted
-
Getz PharmaCompletedQuality of Life | Type 2 Diabetes | Metformin+SitagliptinPakistan
-
Karolinska InstitutetCompletedMyocardial Infarction | Diabetes Mellitus | Impaired Glucose Tolerance | Unstable Angina PectorisSweden
-
University of LeicesterNovo Nordisk A/S; University Hospitals, LeicesterCompletedCardiovascular Disease | Type 2 Diabetes MellitusUnited Kingdom
-
Garvan Institute of Medical ResearchCompleted
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Tehran University of Medical SciencesCompletedUncontrolled Type 2 Diabetes MellitusIran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Puerto Rico, United Kingdom, Ireland, Germany, Slovenia, Canada, France, Italy, Spain, Netherlands, Slovakia, Romania, Former Serbia and Montenegro
-
University Medical Centre LjubljanaCompletedPolycystic Ovary Syndrome | Body Weight
-
Royal Adelaide HospitalMerck Sharp & Dohme LLCCompletedDiabetes Mellitus | GastroparesisAustralia
-
Merck Sharp & Dohme LLCCompletedRenal Insufficiency | Hemodialysis
-
Seoul National University Bundang HospitalCompletedDiabetesKorea, Republic of
-
Samuel Lunenfeld Research Institute, Mount Sinai...Merck Sharp & Dohme LLCCompleted
-
GlaxoSmithKlineActive, not recruitingNeoplasms | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)United States, Hungary, Israel, Spain, Taiwan, France, Australia, Germany, Belgium, Canada, Singapore, Korea, Republic of, United Kingdom, Denmark, Austria, Romania, Italy, Bulgaria, Poland, Netherlands
-
M.D. Anderson Cancer CenterGlaxoSmithKlineRecruiting
-
Brigham and Women's HospitalCompletedChronic Kidney DiseaseUnited States
-
Virginia Commonwealth UniversityJanssen Scientific Affairs, LLCCompletedDiabetes Mellitus, Type 2 | Heart Failure, SystolicUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
AstraZenecaCompletedType 2 Diabetes MellitusSweden
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Estonia, Germany, Latvia, Spain, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Vanderbilt UniversityCompletedHypertension | Diabetes Type 2United States
-
The Catholic University of KoreaCompletedDiabetes MellitusKorea, Republic of
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Canada, Germany, Australia
-
Medanta, The Medicity, IndiaDiabetes & Endocrinology FoundationRecruiting
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingDecompensated Cirrhosis | Compensated CirrhosisIndia
-
Shanghai Zhongshan HospitalRecruitingCardiovascular Diseases | Type 2 Diabetes | Cardiac Perfusion DefectChina
-
SK Chemicals Co., Ltd.CompletedHealthy SubjectsKorea, Republic of
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Korea, Republic of, Latvia, Peru, Lithuania, Israel, Norway, Finland, Argentina, Austria, Belgium, Germany, Greece, Guatemala, Hungary, India, Italy, Mexico, Poland, Romania, Slovakia, Venezuela